Dimitar Savov
Fortuna: 100 M $ al 31/07/2026
Fortuna: 100 M $ al 31/07/2026
Dimitar Slavchev Savov currently works at Nika Pharmaceuticals, Inc., as President, Chief Executive Officer, CFO & Director from 2022.
Mr. Savov also formerly worked at Nika BioTechnology, Inc., as Chairman & President.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NIKA PHARMACEUTICALS INC 43,45 % | 18/03/2025 | 455.589.500 ( 43,45 % ) | 97 M $ | 31/07/2026 |
| 31/12/2024 | 15.000.000 ( 100 % ) | 3 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NIKA PHARMACEUTICALS, INC. | Director Ejecutivo | 01/04/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| NIKA BIOTECHNOLOGY, INC. | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Nika BioTechnology, Inc.
Nika BioTechnology, Inc. Precious MetalsNon-Energy Minerals Engages in exploration of for gold, silver and copper | Non-Energy Minerals |
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and distributes dietary supplements and antiviral drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.